IP receptor (prostacyclin pathway) drugs for Idiopathic Pulmonary Fibrosis

2 tracked IP receptor (prostacyclin pathway) drugs in the Idiopathic Pulmonary Fibrosis race. The class explanation lives on the IP receptor (prostacyclin pathway) page; the full indication pipeline across every mechanism is on the Idiopathic Pulmonary Fibrosis page.

1 Phase 31 preclinical / unstaged

The roster

← all IP receptor (prostacyclin pathway) drugs